Product Images Truseltiq

TRUSELTIQ (infigratinib) capsules are for oral use only and are Rx only. One treatment cycle contains 21 capsules that are taken daily for 21 days followed by a treatment-free period of 7 days. The daily dose of the capsules is 100 mg, and the package contains a blister card. The LIFT PANEL instructions describe how to remove the card from the package. The available text does not provide additional information.*

The text seems to be a mix of different information, such as instructions for taking capsules (specifically "TRUSELTIQ" capsules), a schedule with treatment-free days, references to a CAD file and ITEM#, and a disclaimer that disclaims responsibility for damages or errors in the reproduction of certain materials. There is also a mention of PANTONE® colors and a recommendation to use their swatch guide for accurate color representation. Therefore, it is not clear what the overall description should pertain to, but it appears to be a set of instructions or information regarding the capsules and some associated documentation or materials.*

This is a description for a medicine called "infigratinib". The dosages available are 100mg and 25mg per capsule, and both capsules should be taken daily at the same time. However, the rest of the text appears to be miscellaneous and not legible.*

TRUSELTIQ is a drug that is taken orally, with a 125mg daily dose. The drug comes in capsules which are contained within a blister pack. Each treatment cycle contains 42 capsules, with day 22 to day 28 being free of treatment. The drug is only available with a prescription (Rx Only) and has a unique identifying number of NDC-72730-101-01. There is some unclear text at the end regarding copyright and reproduction rights.*

Truseltiq (infigratinib) capsules are for oral use and are available in blister cards containing one treatment cycle for 25mg and 42 capsules. The daily dose is 50mg. The packaging includes instructions to push the button gently using the thumb and holding it while pulling out the card. The remaining text appears to be a disclaimer and instructions for use, but the quality is too poor to determine this with any certainty.*

This document appears to be medication instructions for a drug called "TRUSELTIQ", which comes in 25mg capsules. The instructions indicate that the patient should take two capsules daily and feature a calendar with specific days marked for dosing. There are also warnings and legal disclaimers printed on the page, as well as technical specifications related to the printing process.*

This is a printed document containing information about Truseltiq capsules. It outlines the recommended dosage and schedule, cautions the reader to check for errors, and includes legal information about copyright and reproduction. There is also a reference to a CAD file and a product number.*

TRUSELTIQ is a Rx Only drug containing infigratinib in the form of 75 mg capsules. Patients should take three 25 mg capsules together once daily for a total of seven days. Each blister card contains 42 capsules for Days 1-14. There are instructions on the card detailing how to open it. There are various codes and numbers on the card, but their meaning is not clear.*

The text appears to be a medication label for Infigratinib capsules, also known as TRUSELTI, with a dosage of 25mg per capsule. The label provides instructions on how to take the medication and includes a calendar to track dosage. There is also information about copyright and reproduction rights for materials submitted to WestRock.*

This is a product description for Truseltiq capsules that recommend taking all three capsules at the same time daily for 7 days, followed by 7 treatment-free days. However, the rest of the text is not readable or does not contain any relevant information.*

TRUSELTIQ (infigratinib) capsules are for oral use only and are available as 75 mg daily dose packed in a blister card containing 21 capsules for Days 15-21 and 21 capsules for Days 22-28. The daily dose should be taken by ingesting three 25 mg capsules together once daily. The instructions on the blister card can be followed to open the capsules. The text also mentions copyright and reproduction rights related to materials submitted by customers to WestRock.*

TRUSELTIQ is a prescription medicine used to treat adults with bile duct cancer. The medicine can only be used if the patient has received a previous treatment, and their tumor has a particular type of abnormal "FGFR2" gene. Before taking this medicine, patients must test their cancer for certain FGFR2 gene abnormalities. TRUSELTIQ can harm unborn babies, and so pregnant people should not start treatment with TRUSELTIQ. Females who can become pregnant should use effective birth control during treatment and for a month after their last dose. Males with female partners who can become pregnant should also use effective birth control during treatment and for 1 month after their final dose. TRUSELTIQ should be taken one time each day for 21 days, followed by seven days off treatment. It should be taken on an empty stomach, at least 1 hour before or 2 hours after food. Patients should swallow capsules whole with a glass of water and not crush, chew, or dissolve them. Patients should talk to their healthcare provider about the birth control methods that may be right for them during this time.*